| Literature DB >> 35742075 |
Zdeněk Vilímek1, Jiří Kantor1, Jakub Krejčí2, Zbyněk Janečka2, Zuzana Jedličková2, Anna Nekardová1, Michal Botek2, Monika Bucharová1, Elsa A Campbell1,3.
Abstract
BACKGROUND: Vibroacoustic therapy (VAT) uses low-frequency sound, often combined with listening to music, for therapeutic purposes. However, the impact of low-frequency vibration (LFV) on physiological functions and subjective perception is relatively unknown.Entities:
Keywords: cardiac autonomic regulation; heart rate variability; low frequency vibration; mood; nature sound; stress; subjective perception; vibroacoustic therapy
Year: 2022 PMID: 35742075 PMCID: PMC9223227 DOI: 10.3390/healthcare10061024
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Rehabilitation vibration bed VIBROBED® (from the authors’ archive).
Figure 2Vibrating lounger VIBRATICS I (from the authors’ archive).
Figure A1Visualisation of Amplitude Modulation used by Vibrobed.
Parameters of audio-recording for Vibrobed.
| AM 1 (14 s) | AM 2 (10 s) | AM 3 (6 s) | Calibration 40 Hz | |||||
|---|---|---|---|---|---|---|---|---|
| Zone (Vibrobed) | dBmax | Pmax (W) | dBmax | Pmax (W) | dBmax | Pmax (W) | −15 dB RMS | W |
| Z1 | −9.15 | 0.89 | −9 | 0.92 | −10.1 | 0.71 | 0.68 | 0.23 |
| Z2 | −9.15 | 0.86 | −9 | 0.89 | −10.1 | 0.69 | 0.67 | 0.22 |
| Z3 | −9.15 | 1.02 | −9 | 1.06 | −10.1 | 0.82 | 0.73 | 0.27 |
| Z4 | −9.15 | 1.02 | −9 | 1.06 | −10.1 | 0.82 | 0.73 | 0.27 |
Z1—calves area; Z2—thighs area; Z3—low back area; Z4—upper back area; Pmax (W)—Nominal Power (Watt); dBmax—Maximum decibel level; RMS (Root mean squer)—Average transducers power.
Figure 3Procedure of the research experiment with outcome measures used (VAS-S and UWIST-MACL were included in the questionnaire before/after the intervention).
Influence of low-frequency sound on heart rate variability indices in pre/post-test measures.
| Variable | Time | Intervention | Interaction |
|---|---|---|---|
|
|
|
| |
| HRStanding (beats/min) | 0.010 | 0.21 | 0.76 |
| HRSupine (beats/min) | <0.001 | 0.054 | 0.68 |
| Ln LFStanding (ms2) | <0.001 | 0.11 | 0.28 |
| Ln LFSupine (ms2) | 0.072 | 0.63 | 0.90 |
| Ln HFStanding (ms2) | <0.001 | 0.12 | 0.99 |
| Ln HFSupine (ms2) | 0.019 | 0.88 | 0.85 |
| Ln LF/HFStanding | <0.001 | 0.31 | 0.076 |
| Ln LF/HFSupine | 0.57 | 0.80 | 0.98 |
p—significance of ANOVA factors; HR—heart rate; Standing—standing body position in orthoclinostatic maneuver; Supine—supine body position in orthoclinostatic maneuver; Ln—natural logarithm; LF—low-frequency power; HF—high-frequency power; LF/HF = LF/HF ratio.
Figure 4Influence of low-frequency sound on heart rate (a,b); low-frequency power (c,d); high-frequency power (e,f); and low-frequency/high-frequency ratio (g,h) in pre/post measures. Standing—standing body position in the orthoclinostatic maneuver; Supine—supine body position in the orthoclinostatic maneuver; Ln—natural logarithm; Sup—placebo supine; Seq—stimulation with amplitude modulation of LFV; Con—constant LFV. The values displayed above the clips are p-values of Fisher’s LSD tests.
Influence of low-frequency sound on heart rate variability indices during intervention.
| Variable | Time | Intervention | Interaction |
|---|---|---|---|
|
|
|
| |
| HRInt (beats/min) | 0.42 | <0.001 | >0.99 |
| Ln LFInt (ms2) | 0.041 | 0.19 | 0.84 |
| Ln HFInt (ms2) | 0.35 | 0.23 | >0.99 |
| Ln LF/HFInt | 0.20 | 0.011 | 0.76 |
p—significance of ANOVA factors; HR—heart rate; Int—intervention; Ln—natural logarithm; LF—low-frequency power; HF—high-frequency power; LF/HF = LF/HF ratio.
Figure 5Influence of low-frequency sound on heart rate (a); low-frequency power (b); high-frequency power (c); and low-frequency/high-frequency ratio (d) during intervention lasting 4 × 5 min (Int1 to Int4). Ln—natural logarithm; Sup—placebo supine; Seq—stimulation with amplitude modulation of LFV; Con—constant LFV. The values displayed above the clips are p-values of ANOVA contrasts.
Figure 6Influence of low-frequency sound on stress assessed by means of visual analogue scale in pre/post measures. Sup—placebo supine; Seq—sequentially dosed amplitude; Con—continuous amplitude. The values displayed above the clips are p-values of Fisher’s LSD tests.
Figure 7Influence of low-frequency sound on two items of UWIST – Sluggish (a) and Active (b) in pre/post measures. Sup—placebo supine; Seq—stimulation with amplitude modulation of LFV; Con –constant LFV. The values displayed above the clips are p-values of Fisher’s LSD tests.